Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...
The history of antibiotic resistance ... of the USA and worldwide. MRSA is the etiologic agent for a wide range of clinical illness, ranging from common skin infections such as impetigo and ...
Medically reviewed by Susan Bard, MD Having psoriasis, an autoimmune condition that causes inflamed skin patches, can make ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Basilea will seek approval of ceftobiprole for SAB as well as acute bacterial skin and skin structure infection (ABSSSI ... % of the total market for anti-MRSA antibiotics, so FDA approval ...
Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and CMC (Chemistry ...
Antibiotics are also used alongside most ... with NFL players reporting MRSA skin infections. It demonstrates that no-one is entirely safe from this risk and superbugs threaten to set back ...
NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...
aeruginosa infection can often receive adequate MSSA coverage with antipseudomonal agents (with the exception of ceftazidime and aztreonam). The intravenous options for MRSA are generally limited ...
When bacteria become resistant to antibiotics, it makes it more difficult to treat diseases caused by those bacteria and limits the treatment options. Alternative treatments may be costly and, in some ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
The study identifies new cell types within the skin that are targeted by EBOV during infection and ... This Prototype Sunscreen Protects Your Skin and Cools You Off, Too Dec. 19, 2024 — Wearing ...